Author Archives: Cindy Affandi

Novel Validated Approach Monitoring Infant Growth Home Clinical Trials

R&D SERVICES/CRO

SPRIM PRO Announces a Novel and Validated Approach for Monitoring Infant Growth from Home in Clinical Trials, Reducing Burdens on Caregivers and Clinical Sites
September 24, 2024

September 24, 2024, SPRIM PRO – SPRIM PRO, a CRO renowned for its innovative approach...

Read more
Obviohealth Strategic Investment By Guardant Health

DIGITAL CLINICAL SOLUTION

ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally
July 29, 2024

July 25, 2024 – (PRNewswire) – ObvioHealth, a global digital clinical trials company, announces a...

Read more
Mimi Tang Prota Therapeutics Forbes Australia

BIOTECH

Forbes Australia recognizes Prota Therapeutics for making waves in Australia’s startup scene at the moment
June 24, 2024

June 18, 2024 – (Forbes Australia) – Founder and CEO Mimi Tang has spent almost...

Read more
Biosenic On Its Way To Find The Necessary Funds To Perform Its Key Clinical Trial On Chronic Graft Versus Host Disease

BIOTECH

Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments
January 16, 2024

Prota Therapeutics Pty Ltd (Prota), an Australian biotechnology company focused on the development of novel...

Read more
Spexis Provides Update Regarding Debt Restructuring Moratorium

BIOTECH

Stalicla Secures $17.4 Million in Series B Financing
January 16, 2024

Stalicla SA, a clinical-stage biopharmaceutical company advancing precision medicine pipelines for neuropsychiatric and neurological disorders,...

Read more
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.
Accept